SCHEMBL29659648

SCHEMBL29659648

CCNc1nc(NCc2ccco2)c2ncn(C3CCCCO3)c2n1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ FLT3 P36888 3/20 0.52
▸ YTHDC1 Q96MU7 1/20 0.49
▸ CCNE1 P24864 5/20 0.49
▸ CDK2 P24941 5/20 0.49
▸ CDK1 P06493 5/20 0.47
▸ TDP1 Q9NUW8 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ ADORA2B P29275 1/20 0.43
▸ ADORA1 P30542 1/20 0.43
▸ CCNB2 O95067 1/20 0.43
▸ CCNB1 P14635 1/20 0.43
▸ CCNB3 Q8WWL7 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547610 1.00 NPC1 (0.52) NPC1RAB9ASMN1; SMN2FLT3YTHDC1
SCHEMBL20547474 0.97 FLT3 (0.49) NPC1RAB9ASMN1; SMN2FLT3YTHDC1
SCHEMBL20547188 0.92 YTHDC1 (0.55) NPC1RAB9ASMN1; SMN2FLT3YTHDC1
SCHEMBL29659534 0.92 YTHDC1 (0.55) NPC1RAB9ASMN1; SMN2FLT3YTHDC1
SCHEMBL30675136 0.89 SMN1; SMN2 (0.51) NPC1RAB9ASMN1; SMN2FLT3YTHDC1
SCHEMBL20547532 0.89 YTHDC1 (0.51) NPC1RAB9ASMN1; SMN2FLT3YTHDC1
SCHEMBL29659620 0.89 YTHDC1 (0.51) NPC1RAB9ASMN1; SMN2FLT3YTHDC1
SCHEMBL20547180 0.89 SRC (0.54) NPC1RAB9ASMN1; SMN2FLT3YTHDC1
SCHEMBL29659565 0.89 SRC (0.54) NPC1RAB9ASMN1; SMN2FLT3YTHDC1
SCHEMBL20547207 0.88 NPC1 (0.51) NPC1RAB9ASMN1; SMN2FLT3YTHDC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615535-B1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIV PALACKEHO (CZ) 2022-06-15 — — EP claimed
Send feedback